招银国际看好讯飞医疗科技的高成长性，首予“买入”评级，目标价170.56港元。讯飞医疗是医疗AI领域领军企业，得益于政策扶持和智能化升级需求，收入快速增长，预计2023-2026年复合增速达36.9%。公司推出星火医疗大模型，深化与头部医院合作，夯实领先优势，并持续扩张客户基础。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.